Vivo Capital, LLC Q2 2025 Filing
Filed August 14, 2025
Portfolio Value
$977.1B
Holdings
42
Report Date
Q2 2025
Filing Type
13F-HR
All Holdings (42 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SLNOSoleno Therapeutics Inc | 3,958,294 | $331.6B | 33.94% | |
| 2 | VRNAVerona Pharma PLC | 1,393,432 | $131.8B | 13.49% | |
| 3 | CDTXCidara Therapeutics, Inc. | 1,311,425 | $63.9B | 6.54% | |
| 4 | GONGeron Corp | 27,225,292 | $38.4B | 3.93% | |
| 5 | SVASinovac Biotech Ltd. | 5,903,000 | $38.2B | 3.91% | |
| 6 | ORICOric Pharmaceuticals Inc | 3,126,604 | $31.7B | 3.25% | |
| 7 | TERNTerns Pharmaceuticals Inc | 6,895,746 | $25.7B | 2.63% | |
| 8 | TRVITrevi Therapeutics Inc | 4,487,903 | $24.5B | 2.51% | |
| 9 | AVDLAvadel Pharmaceuticals PLC | 2,684,109 | $23.8B | 2.43% | |
| 10 | AKROAkero Therapeutics Inc | 434,689 | $23.2B | 2.37% | |
| 11 | CMPXCompass Therapeutics Inc | 6,043,466 | $15.7B | 1.61% | |
| 12 | VRDNViridian Therapeutics Inc | 982,576 | $13.7B | 1.41% | |
| 13 | CTMXCytomx Therapeutics Inc | 5,769,230 | $13.1B | 1.34% | |
| 14 | ACRSAclaris Therapeutics, Inc. | 8,888,888 | $12.6B | 1.29% | |
| 15 | ZBIOZenas Biopharma Inc | 1,183,260 | $11.5B | 1.17% | |
| 16 | DYNDyne Therapeutics Inc | 1,114,960 | $10.6B | 1.09% | |
| 17 | ABEOAbeona Therapeutics, Inc. | 1,842,751 | $10.5B | 1.07% | |
| 18 | DBVTDBV Technologies SA | 1,054,506 | $9.7B | 0.99% | |
| 19 | TRMLTourmaline Bio Inc. | 591,882 | $9.5B | 0.97% | |
| 20 | RZLTRezolute Inc | 2,112,432 | $9.4B | 0.96% | |
| 21 | CMPSCompass Pathway PLC | 3,362,385 | $9.4B | 0.96% | |
| 22 | CRVSCorvus Pharmaceuticals Holdings | 2,234,566 | $8.9B | 0.91% | |
| 23 | ERASErasca Inc | 6,756,756 | $8.6B | 0.88% | |
| 24 | IOBTIO Biotech Inc | 6,173,439 | $8.6B | 0.88% | |
| 25 | CATBUSDAstria Therapeutics Inc | 1,552,685 | $8.3B | 0.85% | |
| 26 | CELCCelcuity Inc | 610,500 | $8.2B | 0.83% | |
| 27 | COGTCogent Biosciences Inc | 1,122,471 | $8.1B | 0.82% | |
| 28 | DCTHDelcath Systems, Inc. | 569,526 | $7.7B | 0.79% | |
| 29 | PRAXPraxis Precision Medicines | 167,600 | $7.0B | 0.72% | |
| 30 | DRUGBright Minds Biosciences Inc | 251,572 | $6.6B | 0.67% | |
| 31 | OLMAOlema Pharmaceuticals Inc | 1,505,862 | $6.4B | 0.66% | |
| 32 | SLNSilence Therapeutics PLC | 1,105,454 | $6.4B | 0.66% | |
| 33 | VSTMVerastem Inc | 1,538,461 | $6.4B | 0.65% | |
| 34 | TILInstil Bio Inc | 292,743 | $6.1B | 0.62% | |
| 35 | UNCYUnicycive Therapeutics | 1,137,015 | $5.4B | 0.56% | |
| 36 | SERASera Prognostics Inc | 1,650,440 | $4.6B | 0.47% | |
| 37 | ETNBGBP89Bio Inc | 376,804 | $3.7B | 0.38% | |
| 38 | TNGXTango Therapeutics Inc | 600,000 | $3.1B | 0.31% | |
| 39 | SRZNSurrozen Inc | 260,000 | $2.3B | 0.24% | |
| 40 | TENXTenax Therapeutics Inc | 208,333 | $1.2B | 0.12% | |
| 41 | BOLTBolt Therapeutics Inc | 176,064 | $986.0M | 0.10% | |
| 42 | DTILPrecision Biosciences Inc | 4,675 | $19.6M | 0.00% |